About Dr. Ross
Owen A. Ross, Ph.D., a native of the north of Ireland, obtained the Ph.D. degree — with a focus on the genetics of aging — in 2003 from the University of Ulster, Ireland. His first postdoctoral position was at Queens University Belfast, Ireland, where he investigated genetic variations of the alpha-synuclein gene in Parkinson's disease and dementia with Lewy bodies.
In 2005, he joined the Department of Neuroscience at the Mayo Clinic campus in Florida to work in the laboratory of Matthew J. Farrer, Ph.D. (now at the University of British Columbia). Dr. Ross has helped to elucidate the role of LRRK2 genetics in Parkinson's disease and is a co-author of more than 30 publications on the subject. His work includes the identification of the most common genetic cause of Parkinson's disease (LRRK2 G2019S) and the first common functional risk factors for the disease (LRRK2 R1628P and G2385R).
For his work on LRRK2 G2019S with Dennis W. Dickson, M.D., Dr. Ross received an honorable mention for the Moore Award in clinicopathologic research at the 81st annual meeting of the American Association of Neuropathologists in 2005. Dr. Ross is an assistant professor of neuroscience in the College of Medicine, Mayo Clinic, and his primary research interest is the genetics of neurodegenerative disorders, specifically stroke and Parkinson's disease. Dr. Ross' research group is focused on the investigation of genetic variation in both familial and sporadic forms of ischemic and hemorrhagic stroke.